← FDA Drug Approvals (Drugs@FDA)
ERTAPENEM SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2023-05-02
Drug application
- FDA Application #
ANDA209145- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERTAPENEM SODIUM
- Generic name
- Ertapenem Sodium
- Active ingredients
- ERTAPENEM SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- SUN PHARM
- First approval
- 2023-05-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown